Ceribell Stock Performance
| CBLL Stock | 20.61 0.18 0.88% |
CeriBell holds a performance score of 23 on a scale of zero to a hundred. The firm shows a Beta (market volatility) of 1.46, which signifies a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, CeriBell will likely underperform. Use CeriBell treynor ratio, kurtosis, period momentum indicator, as well as the relationship between the downside variance and day median price , to analyze future returns on CeriBell.
Risk-Adjusted Performance
Solid
Weak | Strong |
Compared to the overall equity markets, risk-adjusted returns on investments in CeriBell are ranked lower than 23 (%) of all global equities and portfolios over the last 90 days. Despite quite conflicting essential indicators, CeriBell disclosed solid returns over the last few months and may actually be approaching a breakup point. ...more
Actual Historical Performance (%)
One Day Return 0.88 | Five Day Return (7.79) | Year To Date Return (3.24) | Ten Year Return (17.56) | All Time Return (17.56) |
1 | Ceribell Reports Third Quarter 2025 Financial Results | 11/04/2025 |
2 | Acquisition by Xingjuan Chao of 90950 shares of CeriBell, subject to Rule 16b-3 | 11/10/2025 |
3 | Disposition of 1472 shares by Raymond Woo of CeriBell, at 2.24 subject to Rule 16b-3 | 11/11/2025 |
4 | Disposition of 25000 shares by Xingjuan Chao of CeriBell, at 2.24 subject to Rule 16b-3 | 11/21/2025 |
5 | Disposition of 25000 shares by Xingjuan Chao of CeriBell, at 3.65 subject to Rule 16b-3 | 12/01/2025 |
6 | Josef Parvizi Sells 25,000 Shares of CeriBell Stock - MarketBeat | 12/11/2025 |
7 | CeriBell, Inc. Given Average Recommendation of Moderate Buy by Analysts - MarketBeat | 12/17/2025 |
8 | CeriBell CFO Sells 756,000.00 in Stock - MarketBeat | 12/29/2025 |
9 | Disposition of 2500 shares by Robertson Rebecca B of CeriBell at 2.24 subject to Rule 16b-3 | 01/02/2026 |
10 | Disposition of 1472 shares by Raymond Woo of CeriBell at 21.29 subject to Rule 16b-3 | 01/06/2026 |
11 | Is CeriBell Inc. stock a buy on dips - 2025 Top Decliners Long-Term Safe Return Strategies - ulpravda.ru | 01/08/2026 |
12 | CeriBell Maps 2026 Growth at JPMorgan MedTech, Eyes Delirium and Stroke EEG Expansion | 01/14/2026 |
13 | Disposition of 25000 shares by Parvizi Josef of CeriBell at 22.94 subject to Rule 16b-3 | 01/15/2026 |
14 | Ceribell director Parvizi sells 573k in shares - Investing.com | 01/20/2026 |
15 | BTIG Reiterates Buy Rating for CeriBell with 30 Price Ta - GuruFocus | 01/28/2026 |
| Begin Period Cash Flow | 34.5 M | |
| Total Cashflows From Investing Activities | -1.6 M |
CeriBell Relative Risk vs. Return Landscape
If you would invest 1,134 in CeriBell on November 3, 2025 and sell it today you would earn a total of 927.00 from holding CeriBell or generate 81.75% return on investment over 90 days. CeriBell is currently generating 1.0234% in daily expected returns and assumes 3.3871% risk (volatility on return distribution) over the 90 days horizon. In different words, 30% of stocks are less volatile than CeriBell, and 80% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
CeriBell Target Price Odds to finish over Current Price
The tendency of CeriBell Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
| Current Price | Horizon | Target Price | Odds to move above the current price in 90 days |
| 20.61 | 90 days | 20.61 | about 29.46 |
Based on a normal probability distribution, the odds of CeriBell to move above the current price in 90 days from now is about 29.46 (This CeriBell probability density function shows the probability of CeriBell Stock to fall within a particular range of prices over 90 days) .
Given the investment horizon of 90 days the stock has the beta coefficient of 1.46 suggesting as the benchmark fluctuates upward, the company is expected to outperform it on average. However, if the benchmark returns are projected to be negative, CeriBell will likely underperform. Additionally CeriBell has an alpha of 0.7122, implying that it can generate a 0.71 percent excess return over Dow Jones Industrial after adjusting for the inherited market risk (beta). CeriBell Price Density |
| Price |
Predictive Modules for CeriBell
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as CeriBell. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.CeriBell Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. CeriBell is not an exception. The market had few large corrections towards the CeriBell's value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold CeriBell, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of CeriBell within the framework of very fundamental risk indicators.α | Alpha over Dow Jones | 0.71 | |
β | Beta against Dow Jones | 1.46 | |
σ | Overall volatility | 4.24 | |
Ir | Information ratio | 0.21 |
CeriBell Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of CeriBell for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for CeriBell can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| CeriBell appears to be risky and price may revert if volatility continues | |
| The company reported the previous year's revenue of 65.44 M. Net Loss for the year was (40.45 M) with profit before overhead, payroll, taxes, and interest of 72.87 M. | |
| CeriBell generates negative cash flow from operations | |
| CeriBell has a poor financial position based on the latest SEC disclosures | |
| Over 82.0% of the company shares are held by institutions such as insurance companies | |
| Latest headline from news.google.com: BTIG Reiterates Buy Rating for CeriBell with 30 Price Ta - GuruFocus |
CeriBell Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of CeriBell Stock often depends not only on the future outlook of the current and potential CeriBell's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. CeriBell's indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 11.9 M | |
| Cash And Short Term Investments | 194.4 M |
CeriBell Fundamentals Growth
CeriBell Stock prices reflect investors' perceptions of the future prospects and financial health of CeriBell, and CeriBell fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on CeriBell Stock performance.
| Return On Equity | -0.6 | ||||
| Return On Asset | -0.29 | ||||
| Profit Margin | (0.63) % | ||||
| Operating Margin | (0.65) % | ||||
| Current Valuation | 610.67 M | ||||
| Shares Outstanding | 37.1 M | ||||
| Price To Book | 4.66 X | ||||
| Price To Sales | 9.23 X | ||||
| Revenue | 65.44 M | ||||
| Gross Profit | 72.87 M | ||||
| EBITDA | (37.32 M) | ||||
| Net Income | (40.45 M) | ||||
| Total Debt | 21.96 M | ||||
| Book Value Per Share | 4.43 X | ||||
| Cash Flow From Operations | (35.04 M) | ||||
| Earnings Per Share | (3.67) X | ||||
| Market Capitalization | 764.54 M | ||||
| Total Asset | 225.41 M | ||||
| Retained Earnings | (166.94 M) | ||||
| Working Capital | 204.28 M | ||||
About CeriBell Performance
By examining CeriBell's fundamental ratios, stakeholders can obtain critical insights into CeriBell's financial health, operational efficiency, and overall profitability. These insights assist in making well-informed investment and management decisions. For example, a high Return on Assets and Return on Equity would indicate that CeriBell is effectively utilizing its assets and equity to generate significant profits, enhancing its appeal to investors. On the other hand, low ROA and ROE values could reveal issues in asset and equity management, highlighting the need for operational improvements.
| Last Reported | Projected for Next Year | ||
| Days Of Inventory On Hand | 334.92 | 341.10 | |
| Return On Tangible Assets | (0.16) | (0.17) | |
| Return On Capital Employed | (0.17) | (0.18) | |
| Return On Assets | (0.16) | (0.17) | |
| Return On Equity | (0.24) | (0.23) |
Things to note about CeriBell performance evaluation
Checking the ongoing alerts about CeriBell for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for CeriBell help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| CeriBell appears to be risky and price may revert if volatility continues | |
| The company reported the previous year's revenue of 65.44 M. Net Loss for the year was (40.45 M) with profit before overhead, payroll, taxes, and interest of 72.87 M. | |
| CeriBell generates negative cash flow from operations | |
| CeriBell has a poor financial position based on the latest SEC disclosures | |
| Over 82.0% of the company shares are held by institutions such as insurance companies | |
| Latest headline from news.google.com: BTIG Reiterates Buy Rating for CeriBell with 30 Price Ta - GuruFocus |
- Analyzing CeriBell's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether CeriBell's stock is overvalued or undervalued compared to its peers.
- Examining CeriBell's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating CeriBell's management team can have a significant impact on its success or failure. Reviewing the track record and experience of CeriBell's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of CeriBell's stock. These opinions can provide insight into CeriBell's potential for growth and whether the stock is currently undervalued or overvalued.
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in CeriBell. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors. For more information on how to buy CeriBell Stock please use our How to buy in CeriBell Stock guide.You can also try the ETFs module to find actively traded Exchange Traded Funds (ETF) from around the world.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of CeriBell. Projected growth potential of CeriBell fundamentally drives upward valuation adjustments. The financial industry is built on trying to define current growth potential and future valuation accurately. Comprehensive CeriBell assessment requires weighing all these inputs, though not all factors influence outcomes equally.
Earnings Share (3.67) | Revenue Per Share | Quarterly Revenue Growth 0.314 | Return On Assets | Return On Equity |
The market value of CeriBell is measured differently than its book value, which is the value of CeriBell that is recorded on the company's balance sheet. Investors also form their own opinion of CeriBell's value that differs from its market value or its book value, called intrinsic value, which is CeriBell's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because CeriBell's market value can be influenced by many factors that don't directly affect CeriBell's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
It's important to distinguish between CeriBell's intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding CeriBell should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. Meanwhile, CeriBell's quoted price indicates the marketplace figure where supply meets demand through bilateral consent.